Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy (NCT01503086) | Clinical Trial Compass
CompletedNot Applicable
Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy
United States45 participantsStarted 2014-07-30
Plain-language summary
This randomized clinical trial studies how well an adaptive computerized cognitive training program works compared to a non-adaptive computerized cognitive training program in treating younger patients with brain tumor who underwent radiation therapy. Providing a computer training program may improve the well-being and quality of life of patients with cognitive (physical and mental) function difficulties caused by radiation therapy to the brain.
Who can participate
Age range6 Years – 16 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient must be newly diagnosed or relapsed/progressed with a brain tumor that has not previously been treated with CRT
* Note: COG therapeutic study participation is not required for ACCL10P1 enrollment
* Patient enrollment must occur within 4 calendar months following completion of CRT
* Reminder: after patient enrollment, baseline testing followed by randomization must occur within 2-4 months after completion of CRT
* The patient must have an identified caregiver who is willing and able to oversee the training practice during the intervention period (ie, for 5-9 weeks starting approximately 3 months after completion of CRT)
* The patient must have access to a telephone and phone number where they can be reached
* The patient and caregiver must have reading, speaking and listening comprehension of English
* All patients and/or their parents or legal guardians must sign a written informed consent (patient assent is also recommended when applicable according to each institution's policy)
* All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met
Exclusion Criteria:
* Patients with pontine glioma are not eligible
* Patients with an estimated survival of less than one year are not eligible
* Patients with a history of traumatic brain injury prior to tumor diagnosis are not eligible
* Patients with a motor, visual, or auditory handicap that prevents computer use (e.g., unr…